Envoy Medical (COCH) Convertible Debt (2022 - 2023)
Envoy Medical's (COCH) quarterly Convertible Debt came in at $2.5 million in Q4 2023, down 92.51% year-over-year from $33.4 million in Q4 2022, and down 37.5% quarter-over-quarter from $4.0 million in Q3 2023.
Powered by 
Analysis
Envoy Medical (COCH) Convertible Debt (2022 - 2023) Analysis & Trends
Envoy Medical has disclosed Convertible Debt across 2 years of filings, most recently posting $2.5 million for Q4 2023.
- In Q4 2023, Convertible Debt fell 92.51% year-over-year to $2.5 million; the TTM figure through Dec 2023 stood at $2.5 million (down 92.51% YoY), while the FY2023 annual figure was $2.5 million, down 92.51% from the prior year.
- Convertible Debt came in at $2.5 million for Q4 2023 at Envoy Medical, down from $4.0 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $33.4 million in Q4 2022 to a low of $2.5 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Envoy Medical | 72.94 Mn | 53.26 Mn | -227,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 14.70 Mn |
| Dec 31, 2022 | 33.40 Mn |